| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.08 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.08 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |